356 related articles for article (PubMed ID: 27580304)
1. Cyclin-dependent kinase inhibitor flavopiridol promotes remyelination in a cuprizone induced demyelination model.
Mi G; Gao Y; Liu S; Ye E; Li Y; Jin X; Yang H; Yang Z
Cell Cycle; 2016 Oct; 15(20):2780-91. PubMed ID: 27580304
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination.
Hoyos HC; Rinaldi M; Mendez-Huergo SP; Marder M; Rabinovich GA; Pasquini JM; Pasquini LA
Neurobiol Dis; 2014 Feb; 62():441-55. PubMed ID: 24184798
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
[TBL] [Abstract][Full Text] [Related]
4. Golli myelin basic proteins stimulate oligodendrocyte progenitor cell proliferation and differentiation in remyelinating adult mouse brain.
Paez PM; Cheli VT; Ghiani CA; Spreuer V; Handley VW; Campagnoni AT
Glia; 2012 Jul; 60(7):1078-93. PubMed ID: 22447683
[TBL] [Abstract][Full Text] [Related]
5. Icariin ameliorates the cuprizone-induced acute brain demyelination and modulates the number of oligodendrocytes, microglia and astrocytes in the brain of C57BL/6J mice.
Cong H; Liang M; Wang Y; Chang H; Du L; Zhang X; Yin L
Brain Res Bull; 2021 Oct; 175():37-47. PubMed ID: 34274431
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine ameliorates neuropathological changes and increases IGF-1 expression in frontal cortex of C57BL/6 mice exposed to cuprizone.
Zhang H; Zhang Y; Xu H; Wang L; Adilijiang A; Wang J; Hartle K; Zhang Z; Zhang D; Tan Q; Kong J; Huang Q; Li XM
Psychiatry Res; 2014 May; 216(3):438-45. PubMed ID: 24613202
[TBL] [Abstract][Full Text] [Related]
7. Diverse Gene Expressions in the Prediction of Cuprizone-Induced Demyelination.
Han SR; Kang YH; Yoo SM; Lee MS; Lee SH
Neurotox Res; 2020 Mar; 37(3):732-742. PubMed ID: 31916130
[TBL] [Abstract][Full Text] [Related]
8. miR-219 attenuates demyelination in cuprizone-induced demyelinated mice by regulating monocarboxylate transporter 1.
Liu S; Ren C; Qu X; Wu X; Dong F; Chand YK; Fan H; Yao R; Geng D
Eur J Neurosci; 2017 Jan; 45(2):249-259. PubMed ID: 27873367
[TBL] [Abstract][Full Text] [Related]
9. Deletion of Nox4 enhances remyelination following cuprizone-induced demyelination by increasing phagocytic capacity of microglia and macrophages in mice.
Yamanaka K; Nakamura K; Shibahara T; Takashima M; Takaki H; Hidaka M; Komori M; Yoshikawa Y; Wakisaka Y; Ago T; Kitazono T
Glia; 2023 Mar; 71(3):541-559. PubMed ID: 36321558
[TBL] [Abstract][Full Text] [Related]
10. Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination.
Silvestroff L; Bartucci S; Pasquini J; Franco P
Exp Neurol; 2012 May; 235(1):357-67. PubMed ID: 22421533
[TBL] [Abstract][Full Text] [Related]
11. Fasudil enhances the phagocytosis of myelin debris and the expression of neurotrophic factors in cuprizone-induced demyelinating mice.
Ding ZB; Han QX; Wang Q; Song LJ; Chu GG; Guo MF; Chai Z; Yu JZ; Xiao BG; Li XY; Ma CG
Neurosci Lett; 2021 May; 753():135880. PubMed ID: 33838256
[TBL] [Abstract][Full Text] [Related]
12. Cuprizone-induced demyelination in the mouse hippocampus is alleviated by phytoestrogen genistein.
Ohgomori T; Jinno S
Toxicol Appl Pharmacol; 2019 Jan; 363():98-110. PubMed ID: 30468814
[TBL] [Abstract][Full Text] [Related]
13. Erinacine S, a small active component derived from Hericium erinaceus, protects oligodendrocytes and alleviates mood abnormalities in cuprizone-exposed rodents.
Fu JT; Yang CJ; Lee LY; Chen WP; Chen YW; Chen CC; Sun YT; Yang CS; Tzeng SF
Biomed Pharmacother; 2024 Apr; 173():116297. PubMed ID: 38394854
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination.
Zhang Y; Zhang H; Wang L; Jiang W; Xu H; Xiao L; Bi X; Wang J; Zhu S; Zhang R; He J; Tan Q; Zhang D; Kong J; Li XM
Schizophr Res; 2012 Jun; 138(1):8-17. PubMed ID: 22555017
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro.
Selvaraju R; Bernasconi L; Losberger C; Graber P; Kadi L; Avellana-Adalid V; Picard-Riera N; Baron Van Evercooren A; Cirillo R; Kosco-Vilbois M; Feger G; Papoian R; Boschert U
Mol Cell Neurosci; 2004 Apr; 25(4):707-21. PubMed ID: 15080898
[TBL] [Abstract][Full Text] [Related]
16. Combination Therapy of Mesenchymal Stem Cell Transplantation and Astrocyte Ablation Improve Remyelination in a Cuprizone-Induced Demyelination Mouse Model.
Madadi S; Shiri E; Pasbakhsh P; Tahmasebi F; Kazemzadeh S; Zibara K; Kashani IR
Mol Neurobiol; 2022 Dec; 59(12):7278-7292. PubMed ID: 36175823
[TBL] [Abstract][Full Text] [Related]
17. Total astragalosides promote oligodendrocyte precursor cell differentiation and enhance remyelination in cuprizone-induced mice through suppression of Wnt/β-catenin signaling pathway.
Yuan J; Xu N; Tao Y; Han X; Yang L; Liang J; Jin H; Zhang X; Wu H; Shi H; Huang F; Wu X
J Ethnopharmacol; 2022 Nov; 298():115622. PubMed ID: 35964820
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase-5 inhibition promotes remyelination by MCP-1/CCR-2 and MMP-9 regulation in a cuprizone-induced demyelination model.
Nunes AK; Rapôso C; de Oliveira WH; Thomé R; Verinaud L; Tovar-Moll F; Peixoto CA
Exp Neurol; 2016 Jan; 275 Pt 1():143-53. PubMed ID: 26515692
[TBL] [Abstract][Full Text] [Related]
19. Conditional Deletion of Foxg1 Alleviates Demyelination and Facilitates Remyelination via the Wnt Signaling Pathway in Cuprizone-Induced Demyelinated Mice.
Dong F; Liu D; Jiang F; Liu Y; Wu X; Qu X; Liu J; Chen Y; Fan H; Yao R
Neurosci Bull; 2021 Jan; 37(1):15-30. PubMed ID: 33015737
[TBL] [Abstract][Full Text] [Related]
20. Cordycepin (3'-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of demyelination.
Jia Y; Li H; Bao H; Zhang D; Feng L; Xiao Y; Zhu K; Hou Y; Luo S; Zhang Y; Xiao L; Chen X; Zhou J; Wang C; Wang G; Yu H; Xiao C; Du J
Int Immunopharmacol; 2019 Oct; 75():105777. PubMed ID: 31357085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
